Press release
Small lymphocytic lymphoma Pipeline Appears Robust With 80+ Companies Actively Working in the Therapeutics Segment | DelveInsight
Stay ahead with the latest insights! Download DelveInsight's comprehensive Small Lymphocytic Lymphoma Pipeline Report to explore emerging therapies, key Small Lymphocytic Lymphoma Companies, and future Small Lymphocytic Lymphoma treatment landscapes @ Small Lymphocytic Lymphoma Pipeline Outlook Report [https://www.delveinsight.com/sample-request/small-lymphocytic-lymphoma-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Small Lymphocytic Lymphoma Pipeline Report
* In May 2025, Merck Sharp & Dohme LLC announced a study is to assess the safety and tolerability and to confirm the dose of nemtabrutinib in combination with venetoclax in participants with R/R CLL/SLL. The primary study hypotheses are that the combination of nemtabrutinib plus venetoclax is superior to VR with respect to progression-free survival (PFS) per 2018 International Workshop on Chronic Lymphocytic Leukemia (iwCLL) criteria as assessed by blinded independent central review (BICR).
* In May 2025, AbbVie announced a phase 2 study, evaluating the efficacy of venetoclax in participants with relapsed or refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) either in presence of 17p deletion (Cohort 1) or those who have failed a B-receptor signaling pathway inhibitor (BCRI) therapy and who have also failed, or were unable to receive chemoimmunotherapy (CIT) irrespective of 17p status (Cohort 2).
* In May 2025, BeiGene announced a study is to evaluate the safety of zanubrutinib (also known as BGB-3111) in chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenstrom macroglobulinemia, mantle cell lymphoma, or marginal zone lymphoma patients who have become intolerant of prior ibrutinib and/or acalabrutinib treatment, by comparing intolerance to adverse event profile as assessed by the recurrence and the change in severity of adverse events.
* DelveInsight's Small Lymphocytic Lymphoma pipeline report depicts a robust space with 80+ active players working to develop 80+ pipeline therapies for Small Lymphocytic Lymphoma treatment.
* The leading Small Lymphocytic Lymphoma Companies such as Loxo Oncology, Chia Tai Tianqing Pharmaceutical Group, Iovance Biotherapeutics, Ascentage Pharma, NovalGen, Pfizer, MingSight Pharmaceuticals, Jiangsu MingSight-Relin Pharmaceutical, TG Therapeutics, and others.
* Promising Small Lymphocytic Lymphoma Therapies such as ofatumumab, Ibrutinib, Obinutuzumab, Chlorambucil, Arzerra, FC infusion, and others.
Discover how the Small Lymphocytic Lymphoma treatment paradigm is evolving. Access DelveInsight's in-depth Small Lymphocytic Lymphoma Pipeline Analysis for a closer look at promising breakthroughs @ Small Lymphocytic Lymphoma Clinical Trials and Studies [https://www.delveinsight.com/sample-request/small-lymphocytic-lymphoma-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Small Lymphocytic Lymphoma Emerging Drugs Profile
* TQ-B3525: Chia Tai Tianqing Pharmaceutical Group
TQ-B3525 is a novel and selective oral PI3K / inhibitor with activity 41 and 138 folds higher than Buparlisib against PI3K and PI3K in pre-clinical research. TQ-B3525 is well-tolerated in Chinese patients with advanced malignancies, and demonstrated high promising antitumor activity in R/R lymphoma patients.Currently,the drug is in Phase I/II stage of Clinical trial evaluation for the treatment of SLL.
* LOXO-305: Loxo Oncology
Pirtobrutinib (LOXO-305), is an investigational, oral, highly-selective non-covalent Bruton's tyrosine kinase (BTK) inhibitor. BTK plays a key role in the B-cell antigen receptor signaling pathway, which is required for the development, activation and survival of normal white blood cells, known as B-cells, and malignant B-cells. BTK is a validated molecular target found across numerous B-cell leukemias and lymphomas including chronic lymphocytic leukemia, mantle cell lymphoma, Waldenstrom's macroglobulinemia, and marginal zone lymphoma. Currently available BTK inhibitors irreversibly inhibit BTK and the long-term efficacy of these therapies can be limited by acquired resistance. Pirtobrutinib was designed to reversibly bind BTK, deliver consistently high target coverage regardless of BTK turnover rate, preserve activity in the presence of the C481 acquired resistance mutations, and avoid off-target kinases that have complicated the development of both covalent and investigational non-covalent BTK inhibitors. Pirtobrutinib is currently being studied in multiple clinical trials. Safety and efficacy have not been established for the uses being studied.
* IOV 2001: Iovance Biotherapeutics
IOV 2001 is an adoptive cell therapy consist of autologous peripheral blood lymphocytes (PBL) being developed by Iovance Biotherapeutics. Currently, the drug is in Phase I/II stage of Clinical trial evaluation for the treatment of SLL.
The Small Lymphocytic Lymphoma pipeline report provides insights into
* The report provides detailed insights about companies that are developing therapies for the treatment of Small Lymphocytic Lymphoma with aggregate therapies developed by each company for the same.
* It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Small Lymphocytic Lymphoma Treatment.
* Small Lymphocytic Lymphoma Companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
* Small Lymphocytic Lymphoma Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
* Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Small Lymphocytic Lymphoma market.
Get a detailed analysis of the latest innovations in the Small Lymphocytic Lymphoma pipeline. Explore DelveInsight's expert-driven report today! @ Small Lymphocytic Lymphoma Unmet Needs [https://www.delveinsight.com/sample-request/small-lymphocytic-lymphoma-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Small Lymphocytic Lymphoma Companies
Loxo Oncology, Chia Tai Tianqing Pharmaceutical Group, Iovance Biotherapeutics, Ascentage Pharma, NovalGen, Pfizer, MingSight Pharmaceuticals, Jiangsu MingSight-Relin Pharmaceutical, TG Therapeutics and others.
Small Lymphocytic Lymphoma pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
* Intra-articular
* Intraocular
* Intrathecal
* Intravenous
* Ophthalmic
* Oral
* Parenteral
* Subcutaneous
* Topical
* Transdermal
Small Lymphocytic Lymphoma Products have been categorized under various Molecule types such as
* Oligonucleotide
* Peptide
* Small molecule
Download DelveInsight's latest report to gain strategic insights into upcoming Small Lymphocytic Lymphoma Therapies and key Small Lymphocytic Lymphoma Developments @ Small Lymphocytic Lymphoma Market Drivers and Barriers, and Future Perspectives [https://www.delveinsight.com/sample-request/small-lymphocytic-lymphoma-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Small Lymphocytic Lymphoma Pipeline Report
* Coverage- Global
* Small Lymphocytic Lymphoma Companies- Loxo Oncology, Chia Tai Tianqing Pharmaceutical Group, Iovance Biotherapeutics, Ascentage Pharma, NovalGen, Pfizer, MingSight Pharmaceuticals, Jiangsu MingSight-Relin Pharmaceutical, TG Therapeutics and others.
* Small Lymphocytic Lymphoma Therapies- ofatumumab, Ibrutinib, Obinutuzumab, Chlorambucil, Arzerra, FC infusion, and others.
* Small Lymphocytic Lymphoma Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
* Small Lymphocytic Lymphoma Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
Which companies are leading the race in Small Lymphocytic Lymphoma drug development? Find out in DelveInsight's exclusive Small Lymphocytic Lymphoma Pipeline Report-access it now! @ Small Lymphocytic Lymphoma Emerging Drugs and Major Companies [https://www.delveinsight.com/sample-request/small-lymphocytic-lymphoma-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Content
* Introduction
* Executive Summary
* Small Lymphocytic Lymphoma: Overview
* Pipeline Therapeutics
* Therapeutic Assessment
* Small Lymphocytic Lymphoma- DelveInsight's Analytical Perspective
* Late Stage Products (Pre-Registration)
* Drug Name : Company Name
* Drug profiles in the detailed report.....
* Last Stage Products (Phase III)
* LOXO-305: Loxo Oncology
* Drug profiles in the detailed report.....
* Mid Stage Products (Phase I/II)
* TQ-B3525: Chia Tai Tianqing Pharmaceutical Group
* Drug profiles in the detailed report.....
* Preclinical and Discovery Stage Products
* Drug name : Company name
* Drug profiles in the detailed report.....
* Inactive Products
* Small Lymphocytic Lymphoma Key Companies
* Small Lymphocytic Lymphoma Key Products
* Small Lymphocytic Lymphoma - Unmet Needs
* Small Lymphocytic Lymphoma - Market Drivers and Barriers
* Small Lymphocytic Lymphoma - Future Perspectives and Conclusion
* Small Lymphocytic Lymphoma Analyst Views
* Small Lymphocytic Lymphoma Key Companies
* Appendix
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=small-lymphocytic-lymphoma-pipeline-appears-robust-with-80-companies-actively-working-in-the-therapeutics-segment-delveinsight]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/small-lymphocytic-lymphoma-pipeline-insight
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Small lymphocytic lymphoma Pipeline Appears Robust With 80+ Companies Actively Working in the Therapeutics Segment | DelveInsight here
News-ID: 4004396 • Views: …
More Releases from ABNewswire
Secure Z100 Jingle Ball MSG Seats Fast with Promo Code CITY10: Dec 12, 2025 at C …
Grab your Z100 Jingle Ball tickets at Madison Square Garden for Dec 12, 2025, fast with CapitalCityTickets.com! Use promo code CITY10 to save instantly. Don't miss performances from top artists, festive vibes, and unforgettable holiday music. Secure the best seats online today and enjoy an epic night of live entertainment at one of New York City's most iconic venues.
The Z100 Jingle Ball is back, lighting up Madison Square Garden (MSG)…
Cheapest Knicks Tickets Basketball Tickets Online - Best Prices Available with P …
Get your New York Knicks tickets online at CapitalCityTickets.com and score the cheapest prices with promo code CITY10. Whether you want courtside action or upper-level seats at Madison Square Garden, fans can enjoy NBA games without overspending. Don't miss live basketball excitement featuring Julius Randle, RJ Barrett, and the Knicks - buy your tickets today for every home game this season.
The 2025-26 NBA season is here, and New York Knicks…
Fiber Optic Cable Market Expected to Reach USD 20.94 Billion by 2030, Driven by …
Mordor Intelligence has published a new report on the Fiber Optic Cable Market, offering a comprehensive analysis of trends, growth drivers, and future projections.
Fiber Optic Cable Market Overview
The Fiber Optic Cable Market size is estimated at USD 13.92 billion in 2025, and is expected to reach USD 20.94 billion by 2030, at a CAGR of 10.46% during the forecast period (2025-2030). The market reflects increasing demand for high-speed internet, 5G…
Upgraded Systems Made Possible with Water Heater Installation in Wilmington
By ensuring reliable systems are available in homes and businesses, Powell's Plumbing & Air has become a trusted resource for essential upgrades and high-quality service.
In Wilmington, NC, demand for modern solutions such as water heater installation near me [https://www.google.com/search?water+heater+installation+near+me&kgmid=/g/1tfqb2fb] continues to grow as property owners look for ways to improve comfort and efficiency. By ensuring reliable systems are available in homes and businesses, Powell's Plumbing & Air has become a…
More Releases for Small
Succeeding Small Launches Small Business Give-Back Giveaway in Celebration of Sm …
Succeeding Small Launches Small Business Give-Back Giveaway in Celebration of Small Business Month
Honoring Local Colorado Springs Businesses That Make a Difference in Their Community
COLORADO SPRINGS, CO - Succeeding Small, a go-to guide for small business success in small business marketing, is celebrating Small Business Month with the launch of its Small Business Give-Back Giveaway - a contest aimed at honoring the small, service-based businesses that make a meaningful difference in…
Small Molecules, Big Impact: The Rise of the Small Molecule Immunomodulators Mar …
Small Molecule Immunomodulators Market worth $270.8 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Small Molecule Immunomodulators Market - (By Product (Disposable, Reusable), By Application (Colorectal, Thoracic, Orthopedic, Ophthalmology, Neurosurgery, Cardiac Surgery, Gynecology, Others), By End User (Hospitals, Ambulatory Surgical Centers, Clinics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to…
Powering Small: Small Gas Engines Market Advances (2023-2032)
"According to the research report, the global small gas engines market was valued at USD 2.75 billion in 2022 and is expected to reach USD 4.23 billion by 2032, to grow at a CAGR of 4.4% during the forecast period."
Polaris Market Research has recently published the latest update on Small Gas Engines Market: By Size, Latest Trends, Share, Huge Growth, Segments, Analysis and Forecast, 2030 that offers detailed market analysis,…
Small Batch Freeze Dryer Market: Increasing Demand for Small-scale Freeze Drying …
Global Small Batch Freeze Dryer Market Overview:
The Small Batch Freeze Dryer market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others.
In recent years, the Small Batch Freeze Dryer market has experienced significant growth, driven by factors such as increasing consumer demand, technological advancements, and…
Global Small Gas Engines Market, Global Small Gas Engines Industry, Covid-19 Imp …
The Small Gas Engines market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The Global Small Gas Engines Market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Small Gas Engines market. The report focuses on well-known providers…
Small Appliances Market: Strategic Assessment of Emerging Technologies in Small …
Small appliances market is forecasted to grow substantially in all market segments through 2016 owing to the rise in living standards and need for more comfort. Small appliance industry consists of home appliances that are movable or partially movable and can be used on tables, counters, or other platforms. The growth of small appliances market is expected to be driven by product innovation, upgradation of existing products, and value-added features…
